WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 12'7001 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 23'5491 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 143'170  143'438  143'618  143'690  143'677  146'763  148'149  138'536 
Births 1'690  1'688  1'679  1'662  1'638  1'337  2'002  2'280 
Surviving infants 1'674  1'672  1'663  1'645  1'621  1'311  1'957  2'217 
Pop. less than 5 years 8'228  8'120  8'005  7'843  7'661  6'465  11'545  10'668 
Pop. less than 15 years 22'105  21'715  21'429  21'284  21'213  26'712  34'007  30'007 
Female 15-49 years 36'643  37'231  37'759  38'252  38'695  39'663  35'927  36'661 

Number of reported case

(Click for retrospective incidence data for Russian Federation (the))
Diphtheria 14  50  771  1'211 
Japanese encephalitis
Measles 2'123  629  129  101  27  4'800  18'370 
Mumps 394  406  510  925  1'535  40'976 
Pertussis 7'220  4'733  4'795  4'056  3'557  29'983  24'960 
Polio* 14 
Rubella 1'003  349  547  1'602  9'618  457'378 
Rubella (CRS) 11 
Tetanus (neonatal)
Tetanus (total) 21  13  10  11  33 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Russian Federation (the))
Vaccine year result method % card seen                                                
BCG          96  95  96  96  98  96 
DTP1          97 
DTP3          97  97  97  98  98  96 
HepB_BD         
HepB3          97  97  97  98  98 
Hib3          90 
JapEnc         
MCV          98  98  98  99  99  97 
MCV2          97  97  97  97  97 
PCV1         
PCV3         
Pol3          98  98  98  98  98  97 
Rota1         
Rota_last         
Rubella1          98  99  98  98  98 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Russian Federation (the))
BCG 96  95  96  96  98  96 
DTP1 97  97  97  99  99  97 
DTP3 97  97  97  98  98  96 
HepB3 97  97  97  98  98 
Hib3 18 
MCV 98  98  98  98  99  97 
PCV3
Pol3 98  97  98  98  98  97 
Rota_last

Number of districts in the country 83  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 days; 7, 14 years; Yes
DT 3, 4.5 months; 1 year; Yes
DTwP 3, 4.5, 6, 18 months; Yes
DTwPHep 6 months; Yes
Dip + 10 years;
HIB 6, 7 months;
HepB 1st day; 1, 6 months; Yes and adults
IPV 3, 4.5 months; Yes
Influenza Yes
MM 12 months; 6 years; Yes
MMR 12 months; 6 years; No
Measles 12 months; 6 years; Yes
Mumps 12 months; 6 years; Yes
OPV 6, 18, 20 months; 14 years; Yes
Rubella 12 months; 6 years; Yes
Td 6-7, 14 years; +10 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number         83  85  88 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR   No  No         

System performance

Total number of districts in country number 83  83  83  83  83  85  88 
Nº districts with DTP3 coverage >=80% number 83  83  83  83  83  85  88 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 83  83  83  83  83     
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100%              

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.